Sažetak sa skupa
https://doi.org/10.26800/LV-142-supp5-14
The use of cladribine in the treatment of multiple sclerosis
Nikola Erceg
; School of Medicine, University of Zagreb, Croatia
Anamaria Dukić
; School of Medicine, University of Zagreb, Croatia
Tereza Gabelić
; School of Medicine, University of Zagreb, Croatia
Sažetak
Multiple sclerosis (MS) is a chronic inflammatory disease that affects the central nervous system. The cause of MS is still unknown, but it is considered to be multifactorial. A combination of clinical examination, radiological, and laboratory methods according to the McDonald diagnostic criteria confirms the diagnosis with high probability. Management of MS includes disease-modifying drugs that show different levels of efficacy. Cladribine is an antimetabolite drug indicated for the treatment of highly active relapsing-remitting MS based on clinical or imaging features.
Ključne riječi
Cladribine; Lymphocyte count; Multiple sclerosis
Hrčak ID:
251653
URI
Datum izdavanja:
27.1.2021.
Posjeta: 451 *